FR940805-2-00061 FR940805-2-00038 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committees; Renewals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) announces the renewal of FDA advisory committees by the Commissioner of Food and Drugs. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92&hyph;463 (5 U.S.C. app. 2)). DATES: Authority for these committees will expire on the dates indicated below unless the Commissioner formally determines that renewal is in the public interest. 1Name of the Committee 1Date of Expiration Anesthetic and Life Support Drugs Advisory Committee May 1, 1996 Blood Products Advisory Committee May 13, 1996 Pulmonary-Allergy Drugs Advisory Committee May 30, 1996 Drug Abuse Advisory Committee May 31, 1996 Science Advisory Board to the National Center for Toxicological Research June 2, 1996 Peripheral and Central Nervous System Drugs Advisory Committee June 4, 1996 Psychopharmacologic Drugs Advisory Committee June 4, 1996 Science Board to the Food and Drug Administration June 26, 1996 FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management Office (HFA&hyph;306), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;2765. Dated: August 1, 1994. Linda A. Suydam, Interim Deputy Commissioner for Operations. [FR Doc. 94&hyph;19095 Filed 8&hyph;4&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
